Niveauet af doxycyclin i blodet hos patienter, der behandles med ORACEA, er lavere end hos patienter, der behandles med konventionelle antimikrobielle formuleringer af doxycyclin.
Doxycycline blood levels in patients treated with ORACEA are lower than in those treated with conventional antimicrobial formulations of doxycycline.